These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24030313)

  • 21. Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature.
    Mort JR; Aparasu RR; Baer RK
    Pharmacotherapy; 2006 Sep; 26(9):1307-13. PubMed ID: 16945053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins.
    Schalekamp T; Klungel OH; Souverein PC; de Boer A
    Arch Intern Med; 2008 Jan; 168(2):180-5. PubMed ID: 18227365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant use and the risk of upper gastrointestinal bleeding in psychiatric patients: a nationwide cohort study in Taiwan.
    Lee YC; Shau WY; Chang CH; Chen ST; Lin MS; Lai MS
    J Clin Psychopharmacol; 2012 Aug; 32(4):518-24. PubMed ID: 22722503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.
    Lin CC; Hu HY; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1119-28. PubMed ID: 24099473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective serotonin re-uptake inhibitors and the risk of bleeding.
    Weinrieb RM; Auriacombe M; Lynch KG; Lewis JD
    Expert Opin Drug Saf; 2005 Mar; 4(2):337-44. PubMed ID: 15794724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors.
    Dall M; Schaffalitzky de Muckadell OB; Møller Hansen J; Wildner-Christensen M; Touborg Lassen A; Hallas J
    Scand J Gastroenterol; 2011 Sep; 46(9):1039-44. PubMed ID: 21554164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of lower gastrointestinal bleeding in low-dose aspirin users.
    Chen WC; Lin KH; Huang YT; Tsai TJ; Sun WC; Chuah SK; Wu DC; Hsu PI
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1542-1550. PubMed ID: 28449186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [SSRI - treatment and bleeding. What risks do we take?].
    Strubel T; Birkhofer A; Mössmer G; Förstl H
    Nervenarzt; 2010 May; 81(5):549-55. PubMed ID: 19693477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective Serotonin Reuptake Inhibitor Use and Risk of Gastrointestinal and Intracranial Bleeding.
    Yuet WC; Derasari D; Sivoravong J; Mason D; Jann M
    J Am Osteopath Assoc; 2019 Feb; 119(2):102-111. PubMed ID: 30688347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant use of SSRIs, NSAIDs/aspirin and gastroprotective drugs among residents of long-term care facilities: a medical record review.
    Bell JS; Taipale HT; Soini H; Pitkälä KH
    Clin Drug Investig; 2011; 31(5):337-44. PubMed ID: 21366362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study.
    Dall M; Schaffalitzky de Muckadell OB; Lassen AT; Hallas J
    Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1383-91. PubMed ID: 21050241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors.
    Bykov K; Schneeweiss S; Donneyong MM; Dong YH; Choudhry NK; Gagne JJ
    Am J Cardiol; 2017 Feb; 119(4):651-657. PubMed ID: 27939386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity.
    Lewis JD; Strom BL; Localio AR; Metz DC; Farrar JT; Weinrieb RM; Nessel L; Brensinger C; Kimmel SE
    Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):328-35. PubMed ID: 18188866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin Reuptake Inhibitors and Risk of Abnormal Bleeding.
    Andrade C; Sharma E
    Psychiatr Clin North Am; 2016 Sep; 39(3):413-26. PubMed ID: 27514297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venlafaxine and risk of upper gastrointestinal bleeding in elderly depression.
    Ghio L; Puppo S; Presta A
    Curr Drug Saf; 2012 Nov; 7(5):389-90. PubMed ID: 23110464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis.
    Becker C; Jick SS; Meier CR
    Ophthalmology; 2017 Nov; 124(11):1635-1639. PubMed ID: 28571893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SSRI/SNRI Therapy is Associated With a Higher Risk of Gastrointestinal Bleeding in LVAD Patients.
    Mawardi G; Markman TM; Muslem R; Sobhanian M; Converse M; Meadows HB; Uber WE; Russell SD; Rouf R; Ramu B; Judge DP; Tedford RJ; Houston BA
    Heart Lung Circ; 2020 Aug; 29(8):1241-1246. PubMed ID: 31635997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study.
    Chen VC; Ng MH; Chiu WC; McIntyre RS; Lee Y; Lin TY; Weng JC; Chen PC; Hsu CY
    PLoS One; 2017; 12(3):e0173005. PubMed ID: 28257449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
    Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
    Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma.
    Chen HY; Lin CL; Lai SW; Kao CH
    J Clin Psychiatry; 2016 Jun; 77(6):e692-6. PubMed ID: 27135704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.